SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-004361
Filing Date
2024-06-20
Accepted
2024-06-20 16:02:22
Documents
16
Period of Report
2024-06-14
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K coeptis_8k.htm   iXBRL 8-K 42224
2 CERTIFICATE OF DESIGNATION coeptis_ex9901.htm EX-99.1 71104
3 PRESS RELEASE coeptis_ex9902.htm EX-99.2 11342
  Complete submission text file 0001683168-24-004361.txt   368391

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE coep-20240614.xsd EX-101.SCH 3873
5 XBRL DEFINITION FILE coep-20240614_def.xml EX-101.DEF 26773
6 XBRL LABEL FILE coep-20240614_lab.xml EX-101.LAB 37006
7 XBRL PRESENTATION FILE coep-20240614_pre.xml EX-101.PRE 25397
19 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_8k_htm.xml XML 6127
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39669 | Film No.: 241056138
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)